All News

Gene Therapy

Stevenage Bioscience Hub’s Lab Hotel Joined by Inspira Pharmaceuticals
10 August 2022
Stevenage Bioscience Hub’s Lab Hotel Joined by Inspira Pharmaceuticals
World-leading life science park Stevenage
Pfizer Acquire Global Blood Therapeutics for $5.4 Billion
9 August 2022
Pfizer Acquire Global Blood Therapeutics for $5.4 Billion
Pfizer has announced it is
Viral vs Non-Viral Vectors
4 August 2022
Viral vs Non-Viral Vectors
For this feature, the Phacilitate
FDA Gives Go-Ahead for New Gene Therapy Clinical Trial in Cystic Fibrosis
2 August 2022
FDA Gives Go-Ahead for New Gene Therapy Clinical Trial in Cystic Fibrosis
Pivotal-stage gene therapy company Krystal
POPULAR NEWS ITEMS
Image
11 August 2022

GentiBio Collab with Bristol Myers Squibb to Pioneer Engineered Treg Therapies for IBD

Image
10 August 2022

Stevenage Bioscience Hub’s Lab Hotel Joined by Inspira Pharmaceuticals

Image
9 August 2022

Pfizer Acquire Global Blood Therapeutics for $5.4 Billion

First Patient Successfully Treated by Ex Vivo Lentiviral Gene Therapy for RAG1-SCID
1 August 2022
First Patient Successfully Treated by Ex Vivo Lentiviral Gene Therapy for RAG1-SCID
Mustang Bio has announced that
Gene Therapy and the Big Debate: Viral Vectors Vs Non-Viral Vectors
29 July 2022
Gene Therapy and the Big Debate: Viral Vectors Vs Non-Viral Vectors
As gene therapies expand their
Scaling Clinical Cell and Gene Therapies
28 July 2022
Scaling Clinical Cell and Gene Therapies
In this webinar, discover how
5 Top Takeaways from ASGCT’S Q2 2022 Quarterly Data Report
25 July 2022
5 Top Takeaways from ASGCT’S Q2 2022 Quarterly Data Report
Phacilitate’s Ryan Leahy summarizes his
Load more News
RECOMENDED TOPICS
Allogeneic
Autologous
CAR-X
Cell Therapy
Cell-Based IO
Gene Editing
Gene Therapy
NKx
Stem Cells
Tissue Engineering
Viral/Non-Viral Vectors
POPULAR NEWS ITEMS
Image

GentiBio Collab with Bristol Myers Squibb to Pioneer Engineered Treg Therapies for IBD

Image

Stevenage Bioscience Hub’s Lab Hotel Joined by Inspira Pharmaceuticals

Image

Pfizer Acquire Global Blood Therapeutics for $5.4 Billion